Establishing Industry Best Practices for Working with Novel Biotherapeutic Entities

Tim Moran of Dassault Systemes BIOVIA writes about HELM in Pharmaceutical Processing: “Recognized by the FDA as an acceptable submission format, HELM is nearing a critical mass of users as a standard notation to represent therapeutic large molecules in bioregistration systems. It is becoming more common for software developers to include APIs that make it easier to provide registration of chemicals and biologics from third-party applications such as electronic lab notebooks (ELNs).”

Posted in Pistoia Alliance Blog and tagged .

Leave a Reply

Your email address will not be published. Required fields are marked *